1981
DOI: 10.1016/0092-8674(81)90445-1
|View full text |Cite
|
Sign up to set email alerts
|

Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

4
168
0

Year Published

1982
1982
1991
1991

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 197 publications
(172 citation statements)
references
References 34 publications
4
168
0
Order By: Relevance
“…The possibility remains that this observed specificity is not a consequence of an interaction between the Py A enhancer and the MoMuLV enhancer but rather to an interaction of the Mo-MuLV enhancer with some other component of the Py genome such as the origin for DNA replication or the early promoter. As all the previously characterized tissue-specific variants of Py and some MoMuLV have been observed, however, to undergo enhancer rearrangements with duplications and deletions of the A and B core sequences (13)(14)(15) and with no changes in the origin of DNA replication or early promoter, we feel that an interaction between the Py A enhancer and the Mo-MuLV enhancer is a likely cause of the pancreatic tissue specificity we observe. With either of these possibilities, however, it remains clear that combinational principles in which distinct genetic elements can act together to yield a different and unique tissue specificity must be invoked to explain this pancreas specificity.…”
Section: Discussionmentioning
confidence: 78%
See 1 more Smart Citation
“…The possibility remains that this observed specificity is not a consequence of an interaction between the Py A enhancer and the MoMuLV enhancer but rather to an interaction of the Mo-MuLV enhancer with some other component of the Py genome such as the origin for DNA replication or the early promoter. As all the previously characterized tissue-specific variants of Py and some MoMuLV have been observed, however, to undergo enhancer rearrangements with duplications and deletions of the A and B core sequences (13)(14)(15) and with no changes in the origin of DNA replication or early promoter, we feel that an interaction between the Py A enhancer and the Mo-MuLV enhancer is a likely cause of the pancreatic tissue specificity we observe. With either of these possibilities, however, it remains clear that combinational principles in which distinct genetic elements can act together to yield a different and unique tissue specificity must be invoked to explain this pancreas specificity.…”
Section: Discussionmentioning
confidence: 78%
“…It appears that alterations in the B enhancer can display a tissue specificity for expression in certain lines of embryonal carcinoma cells (13)(14)(15). In addition to transcriptional regulation, the Py enhancers and also the heterologous immunoglobulin heavy-chain core enhancer regulate permissivity or tissue specificity of Py viral DNA replication (11,16), indicating that some linkage exists between tissuespecific DNA replication and transcription.…”
mentioning
confidence: 99%
“…Polyomavirus mutants that productively infect EC cells have been isolated, and several of the mutations have been mapped to the enhancer region of the early promoter (16,42,53). Expression data provide evidence that the primary block for polyomavirus replication in EC cells is a defect in early viral expression, and the enhancer mutations relieve the defect by activating the early promoter (29).…”
mentioning
confidence: 99%
“…The pluripotential mouse embryonal carcinoma (EC) cell is notable because infection of these cells by polyoma virus results in no virus replication (Swartzendruber & Lehman, 1975) and because no synthesis of polyoma early or late proteins occurs in infected cells (Dandolo et al, 1983 ;Fujimura et al, 1981 a, b). Mutant polyoma viruses (Fujimura et al, 1981a;Katinka et al, 1980Katinka et al, , 1981Sekikawa & Levine, 1981 ;Vasseur et al, 1980) able to grow in EC cells carry alterations in a non-coding region of the viral genome comprising the enhancer (deVilliers & Schaffner, 1981;Tyndall et aL, 1981) of early gene transcription, This suggests that EC cells differ from fibroblast cells in that EC cells do not efficiently transcribe viral genes whose regulation is controlled by enhancers. Direct evidence METHODS Cells and media.…”
Section: Introductionmentioning
confidence: 99%